Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanghai INT Medical Instruments Co (HKSE:01501) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Shanghai INT Medical Instruments Co EBITDA Margin % Related Terms
Shanghai INT Medical Instruments Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai INT Medical Instruments Co EBITDA Margin % Chart
HKSE:01501 vs ISRG, BDX, MDLN: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, Shanghai INT Medical Instruments Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai INT Medical Instruments Co EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shanghai INT Medical Instruments Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Shanghai INT Medical Instruments Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai INT Medical Instruments Co (HKSE:01501) has a EBITDA Margin % of 24.36% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Shanghai INT Medical Instruments Co and its competitors. This is 38% below median its historical median of 39.39. Over the past decade, Shanghai INT Medical Instruments Co's EBITDA Margin % has ranged from 25.42 to 46.21. According to the industry distribution chart, Shanghai INT Medical Instruments Co ranks #125 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 15.3%.
Is Shanghai INT Medical Instruments Co's EBITDA Margin % too high?
Shanghai INT Medical Instruments Co's current EBITDA Margin % of 24.36% is 38% below median its 10-year median of 39.39. Over the past 10 years, this metric has ranged from a low of 25.42 to a high of 46.21. The Medical Devices & Instruments industry median EBITDA Margin % is 7.47. Shanghai INT Medical Instruments Co's value of 24.36% is 226.1% above this industry median. Based on the distribution chart, Shanghai INT Medical Instruments Co ranks #125 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Shanghai INT Medical Instruments Co has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai INT Medical Instruments Co's EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Shanghai INT Medical Instruments Co ranks #125 out of 815 companies for EBITDA Margin %. This places Shanghai INT Medical Instruments Co in the top 15% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 7.47. Shanghai INT Medical Instruments Co's value of 24.36% is 226.1% above this benchmark. Historically, Shanghai INT Medical Instruments Co's own EBITDA Margin % has ranged from 25.42 to 46.21 over the past decade. While the company's 10-year median is 39.39 vs. the industry median of 7.47, Shanghai INT Medical Instruments Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.47, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai INT Medical Instruments Co's current EBITDA Margin % of 24.36% is 226.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Shanghai INT Medical Instruments Co and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai INT Medical Instruments Co's current EBITDA Margin % is 24.36%, which is 38% below median its own 10-year median of 39.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai INT Medical Instruments Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai INT Medical Instruments Co (HKSE:01501) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$39.95, compared to a current price of HK$32.90 — trading 17.6% below its estimated fair value. The current EBITDA Margin % is 24.36%, which is 38% below median its 10-year median of 39.39 and 226.1% above the Medical Devices & Instruments industry median of 7.47. Shanghai INT Medical Instruments Co's overall GF Score™ is 93/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Shanghai INT Medical Instruments Co (HKSE:01501), the current EBITDA Margin % is 24.36% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai INT Medical Instruments Co (HKSE:01501) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai INT Medical Instruments Co stock appears to be undervalued.
The current stock price of HK$32.90 is trading 17.6% below its estimated GF Value™ of HK$39.95.
GuruFocus considers Shanghai INT Medical Instruments Co to be Modestly Undervalued.
Key valuation signals for HKSE:01501:
EBITDA Margin %: 24.36% (38% below median its 10-year median of 39.39)
GF Value™: HK$39.95 vs. price of HK$32.90 (17.6% below fair value)
Industry Position: 226.1% above the Medical Devices & Instruments median (#125 of 815)
No single metric tells the full story. See the HKSE:01501 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai INT Medical Instruments Co Business Description
Shanghai INT Medical Instruments Co Ltd engages in the design and development of medical devices used in fields including peripheral intervention, neurological intervention, cardiovascular intervention, or implantation, and the design and development of equipment and moulds used for the production of medical devices. The company operates in the Chinese Mainland, Europe, the United States, and Other countries and regions. The majority of the revenue comes from the Chinese Mainland.
93GF Score
Get the complete analysis for HKSE:01501
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01501 has been successfully added to your 
